Modular Medical (MODD) Cash from Financing Activities (2020 - 2026)
Modular Medical (MODD) posted Cash from Financing Activities of $10.8 million for Q1 2026, up 80.48% on a QoQ basis from $6.0 million in Q4 2025, and down 4.77% year-over-year from $11.4 million in Q1 2025.
Modular Medical (MODD) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Modular Medical's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $10.8 million for Q1 2026.
- Quarterly Cash from Financing Activities fell 4.77% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (down 2.46% YoY) and the FY2026 annual result came in at $21.5 million, down 2.46% from the prior year.
- Cash from Financing Activities was $10.8 million for Q1 2026 at Modular Medical, up from $6.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $12.0 million in Q1 2022 and bottomed at $181000.0 in Q4 2023.
- A 5-year average of $6.5 million and a median of $7.4 million in 2022 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 4171.27% in 2024, while the deepest fall reached 97.84% in 2024.
- Modular Medical's Cash from Financing Activities stood at $7.4 million in 2022, then tumbled by 97.54% to $181000.0 in 2023, then jumped by 4171.27% to $7.7 million in 2024, then decreased by 22.42% to $6.0 million in 2025, then surged by 80.48% to $10.8 million in 2026.
- Business Quant data shows MODD's Cash from Financing Activities at $10.8 million in Q1 2026, $6.0 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -25.00 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | 21.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | -26.93 Mn |
| 10 | Modular Medical | 5.37 Mn | -1.57 Mn | - | 10.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.83 Mn |
| Mar 31, 2026 | 10.83 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 3.98 Mn |
| Sep 30, 2025 | 3.98 Mn |
| Jun 30, 2025 | 733,000.00 |
| Jun 30, 2025 | 733,000.00 |
| Mar 31, 2025 | 11.37 Mn |
| Mar 31, 2025 | 11.37 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 210,000.00 |
| Mar 31, 2024 | 11.17 Mn |
| Mar 31, 2024 | 11.17 Mn |
| Dec 31, 2023 | 181,000.00 |
| Dec 31, 2023 | 181,000.00 |